stars 1 stars 2 stars 3

Nucrogene Pharmaceuticals Inc, is engaging in development, manufacture, commercialization and market innovative specialty generic prescription medicines as well as a over the counter medicines. Nucrogene generic pharmaceutical develop products with focus on wide range of therapeutic areas including, cardiovascular, proton pump inhibitors, anti-infective and anti-inflammatory diseases and other medical situation in the United States, Latin America, Europe and international market. Dosage forms include immediate release (IR), modified release (MR) and extended release(ER) of tablets, capsules and injectable. Nucrogene’s goal is to come up with innovations in generic medicines, improved quality of life for patients from high quality, cost effective medicines.

Nucrogene Questions

The Nucrogene annual revenue was $5.9 million in 2026.

5 people are employed at Nucrogene.

Nucrogene is based in Branchburg, New Jersey.

The NAICS codes for Nucrogene are [32, 32541, 325, 3254].

The SIC codes for Nucrogene are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users